Phase I, first-in-human clinical trial to evaluate safety of infusion of STAb-T19 cells: genetically modified T lymphocytes secreting αCD19xαCD3 bispecific antibodies for malignant B-cell neoplasms

2025-524814-27-00 Protocol H12O-STAb-T-001 Human pharmacology (Phase I) - First administration to humans Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 4 sites · Protocol H12O-STAb-T-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Authorised, recruitment pending
Participants planned 24
Countries 1
Sites 4

Malignant B-cell neoplasms

Key facts

Sponsor
Fundacion Para La Investigacion Biomédica Del Hospital Universitario 12 De Octubre
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04], Diseases [C] - Hemic and Lymphatic Diseases [C15]
Decision date (initial)
2026-04-22
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Malignant B-cell neoplasms

VersionLevelCodeTermSystem organ class
28.0 LLT 10086816 B-cell non-Hodgkin´s lymphoma refractory 100000004848
28.0 LLT 10084346 B-cell non-Hodgkin´s lymphoma 100000004848
20.1 LLT 10076867 Acute lymphocytic leukemia refractory 10029104
28.1 LLT 10000848 Acute lymphocytic leukemia 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Fundacion Para La Investigacion Biomédica Del Hospital Universitario 12 De Octubre

Sponsor organisation
Fundacion Para La Investigacion Biomédica Del Hospital Universitario 12 De Octubre
Address
Avda De Cordoba, Centro De Actividades Ambulatorias 6a Planta Bloque D Centro De Actividades Ambulatorias 6a Planta Bloque D
City
Madrid
Postcode
28041
Country
Spain

Scientific contact point

Organisation
Fundacion Para La Investigacion Biomédica Del Hospital Universitario 12 De Octubre
Contact name
Dra. María Liz Paciello Coronel

Public contact point

Organisation
Fundacion Para La Investigacion Biomédica Del Hospital Universitario 12 De Octubre
Contact name
Dra. María Liz Paciello Coronel

Locations

1 EU/EEA country · 4 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Authorised, recruitment pending 24 4
Rest of world 0

Investigational sites

Spain

4 sites · Authorised, recruitment pending
Hospital Germans Trias I Pujol
Haematology, Carretera Canyet 1a Planta, 08916, Badalona
Hospital Universitario 12 De Octubre
Haematology, Avenida De Cordoba Sn, 28041, Madrid
Hospital Clinic De Barcelona
Haematology, Calle Villarroel 170, 08036, Barcelona
Hospital Universitario Y Politecnico La Fe
Haematology, Avenida Fernando Abril Martorell 106, 46026, Valencia

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-12-31 Spain Acceptable with conditions
2026-04-20
2026-04-22
2 SUBSTANTIAL MODIFICATION SM-1 2026-05-04 Spain Acceptable
2026-05-21
2026-05-22